
price close busi januari
intuit surgic manufactur da vinci robot system
use wide rang minimally-invass surgic
biomed devic servic
strong fundament reflect prevail
bottom line report strong result line firm
pre-announce earli januari see note manag reiter
full-year procedur growth acceler ahead
benchmark achiev view potenti hit
potenti exceed growth threshold set current calendar year
beyond time-frame expect challeng setup ramp competit
threat well potenti addit player space includ
 j/verb surgic intern continu invest drive pipelin
pro forma opex expect grow level firm invest
sp platform catheter-bas robot technolog imag well drive
expans penetr ou market notwithstand strong growth trend
display robust pipelin portfolio remain hold-rat stock
valuat ascend unpreced level throughout stock current
trade ntm ep significantli multipl share peak
procedur volum growth deliv strong world-wide procedur
growth line firm pre-announce result strength
us gener hernia ventral inguin colorect continu
out-performance us urolog contribut domest procedur volum growth
firm also note result may also seen increment
benefit procedur postpon due hurricanes/fir look forward
manag anticip dvp growth moder come line overal
overal incid rate ou procedur volum growth driven
on-going adopt dvp
product pipelin updat major chang major time chang pipelin
initi announc decemb file urolog indic
da vinci sp platform manag provid time updat beyond
continu view approv launch reason firm
plan phase launch post approv time associ futur sp indic
submiss tor colorect disclos manag note fulli
focus today initi urolog indic beyond urolog view signific
potenti tor colorect indic believ repres
firm best chanc see posit contribut sp procedur volum growth
overal regard isrg flexibl robot program specif market launch
time yet provid manag note progress continu track line
intern expect anticip gener revenu
system single-cent feasibl data australia present past
fall chest meet pre-plan target area reach case
platform demonstr favor safeti profil
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
japan procedur recent recommend reimburs earlier
month receiv posit decis mhlw japan recommend
procedur reimburs final decis around level
reimburs expect prior end current quarter manag
withheld provid specif project given uncertainti around level
reimburs manag note expect modest system
expans japan beyond current system market
guidanc updat manag reiter expect
procedur growth rang compani also issu first-tim pro
forma gm guidanc project gross margin rang
manag expect pro forma opex growth rang
level firm current project incom tax rate rang
figur intuit surgic result vs cg estim consensu project
deriv price target appli ratio line large-
cap med-tech comp group ep model forward ep
compound-annual-growth-rate thu aforement target multipl drive target price-to-earnings
appli pro forma ep estim deriv
target
hold unchang target price januari
biomed devic servic
actual except resultsprior yeary/i growthcg estim varianc forma gross bps-gaap vinci system valuat financi metric use mean large-cap medic devic price-to-earnings multipl ep pro forma price-to-earnings multipl use group forma year-end figur incom statement
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
hold unchang target price januari
biomed devic servic
million except per share total servic total gross total oper oper incom expens pre-tax incom tax expens tax incom share ep pro-forma calcul xi trade-in base compens intang liabil litig invest net forma ex tax analysisduct adjust sbc ia margin pro margin includ margin pro incom cont figur revenu model
hold unchang target price januari
biomed devic servic
total instrument/access total servic total revenu growth modelgrowth rate assumptionsu system unit sale replacements/trad instal base us intern total total sold ex-oper asp modelgrowth rate procedur growth procedur growth procedur growth gener ou urolog gener gynecolog us ww procedur asp revenue/instal system intuit surgic
